A Randomized, Open Label, Cross Over Study to Examine the Impact of Prograf and Advagraf on Tacrolimus Exposure, Mycophenolic Acid Pharmacokinetics, Renal Allograft Function or Adverse Effects.
Phase of Trial: Phase IV
Latest Information Update: 03 Sep 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 31 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Aug 2013 Planned number of patients changed from 40 to 95 as reported by ClinicalTrials.gov.
- 08 Aug 2013 Planned end date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.